The Nanowear Wearable System SimpleSense Validation Trial for Cardiac Output
NCT: NCT05629533 · TERMINATED
Brief Summary
The Nanowear SimpleSense study is a single center, prospective, non-randomized, feasibility, non- significant risk study The study will be done in 2 phases. Phase 1 will use SimpleSense data collected from the first set of subjects and associate the data from SimpleSense to the right heart catheterization values.' Phase 2 will evaluate the algorithms developed to estimate cardiac output from SimpleSense data using a second set of subjects from within the sample population that are sequestered from the first set used for association of data from SimpleSense to the data from the right heart catheterization.
Frequently Asked Questions
What is The Nanowear Wearable System SimpleSense Validation Trial for Cardiac Output?
The Nanowear Wearable System SimpleSense Validation Trial for Cardiac Output is a clinical trial registered under NCT05629533. Current status: TERMINATED.
What is the status of NCT05629533?
The current status of NCT05629533 (The Nanowear Wearable System SimpleSense Validation Trial for Cardiac Output) is: TERMINATED.
When did The Nanowear Wearable System SimpleSense Validation Trial for Cardiac Output start?
The Nanowear Wearable System SimpleSense Validation Trial for Cardiac Output started on 2023-03-08.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.